QGEN
Qiagen NV
NYSE: QGEN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$41.81
-1.11% today
Updated 2026-07-29
Market cap
$8.49B
P/E ratio
20.99
P/S ratio
4.04x
EPS (TTM)
$1.96
Dividend yield
—
52W range
$31 – $54
Volume
2.6M
Qiagen NV (QGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$41.81
12-Month target
$39.87
2030 Target
—
Intrinsic (DCF)
$40.24
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $2.1B | $2.0B | $2.0B | $2.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 20.99x (capped 25x) · Margin: 19.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.